Cross-regulation of T cell growth factor expression by p53 and the tax oncogene

Journal of Immunology

Volumn 169, Issue 12, 2002, Pages 6767-6778

  Chaudhry, Sohail ^a,b   Freebern, Wendy J ^a   Smith, James L ^a   Butscher, Wayne G ^a   Haggerty, Cynthia M ^a   Gardner, Kevin ^a,b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; PROTEIN MDM2; PROTEIN P300; PROTEIN P53; TAX PROTEIN; CD28 ANTIGEN; MDM2 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR AP 1;

APOPTOSIS; ARTICLE; DNA RESPONSIVE ELEMENT; GENE REPRESSION; HUMAN; HUMAN CELL; ONCOGENE; ONCOGENE TAX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION; T LYMPHOCYTE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; BIOSYNTHESIS; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOLOGY; LEUKEMIA CELL LINE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; PROTEIN PROCESSING; REGULATOR GENE; SIGNAL TRANSDUCTION;

ANTIGENS, CD28; APOPTOSIS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG SYNERGISM; GENE EXPRESSION REGULATION; GENES, PX; HUMANS; INTERLEUKIN-2; JURKAT CELLS; LYMPHOCYTE ACTIVATION; NF-KAPPA B; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037114148     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.169.12.6767     Document Type: Article

References (66)

1. Siegel, R. M., F. K. Chan, H. J. Chun, and M. J. Lenardo. 2000. The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. Nat. Immun. 1:469.
2. Thome, M., and J. Tschopp. 2001. Regulation of lymphocyte proliferation and death by FLIP. Nat. Rev. Immunol. 11:50.
3. Evan, G. I., and K. H. Vousden. 2001. Proliferation, cell cycle and apoptosis in cancer. Nature 411:342.
4. Ryan, K. M., A. C. Phillips, and K. H. Vousden. 2001. Regulation and function of the p53 tumor suppressor protein. Curr. Opin. Cell Biol. 13:332.
5. Cesarman, E., A. Chadburn, G. Inghirami, G. Gaidano, and D. M. Knowles. 1992. Structural and functional analysis of oncogenes and tumor suppressor genes in adult T-cell leukemia/lymphoma shows frequent p53 mutations. Blood 80:3205.
6. Ohkusu-Tsukada, K., T. Tsukada, and K. Isobe. 1999. Accelerated development and aging of the immune system in p53-deficient mice. J. Immunol. 163:1966.
7. Gu, W., X. L. Shi, and R. G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819.
8. Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823.
9. Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175.
10. Webster, G. A., and N. D. Perkins. 1999. Transcriptional cross talk between NF-κB and p53. Mol. Cell. Biol. 19:3485.
11. Wadgaonkar, R., K. M. Phelps, Z. Haque, A. J. Williams, E. S. Silverman, and T. Collins. 1999. CREB-binding protein is a nuclear integrator of nuclear factor-κB and p53 signaling. J. Biol. Chem. 274:1879.
12. Livengood, J. A., K. E. Scoggin, K. van Orden, S. J. McBryant, R. Edayathumangalam, P. J. Laybourn, and J. K. Nyborg. 2002. p53 Transcriptional activity is mediated through the SRC1-interacting domain of CBP/p300. J. Biol. Chem. 277:9054.
13. Van Orden, K., H. A. Giebler, I. Lemasson, M. Gonzales, and J. K. Nyborg. 1999. Binding of p53 to the KIX domain of CREB binding protein: a potential link to human T-cell leukemia virus, type I-associated leukemogenesis. J. Biol. Chem. 274:26321.
14. Grossman, S. R., M. Perez, A. L. Kung, M. Joseph, C. Mansur, Z. X. Xiao, S. Kumar, P. M. Howley, and D. M. Livingston. 1998. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell 2:405.
15. Scolnick, D. M., N. H. Chehab, E. S. Stavridi, M. C. Lien, L. Caruso, E. Moran, S. L. Berger, and T. D. Halazonetis. 1997. CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res. 57:3693.
16. Wadgaonkar, R., and T. Collins. 1999. Murine double minute (MDM2) blocks p53-coactivator interaction, a new mechanism for inhibition of p53-dependent gene expression. J. Biol. Chem. 274:13760.
17. Jeang, K. T. 2001. Functional activities of the human T-cell leukemia virus type I Tax oncoprotein: cellular signaling through NF-κB. Cytokine Growth Factor Rev. 12:207.
18. Kwok, R. P., M. E. Laurance, J. R. Lundblad, P. S. Goldman, H. Shih, L. M. Connor, S. J. Marriott, and R. H. Goodman. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the coactivator CBP. Nature 380:642.
19. Scoggin, K. E., A. Ulloa, and J. K. Nyborg. 2001. The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol. Cell. Biol. 21:5520.
20. Mulloy, J. C., T. Kislyakova, A. Cereseto, L. Casareto, A. LoMonico, J. Fullen, M. V. Lorenzi, A. Cara, C. Nicot, C. Giam, and G. Franchini. 1998. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol. 72:8852.
21. Pise-Masison, C. A., R. Mahieux, M. Radonovich, H. Jiang, and J. N. Brady. 2001. Human T-lymphotropic virus type 1 Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent. J. Biol. Chem. 276:200.
22. Pise-Masison, C. A., M. Radonovich, K. Sakaguchi, E. Appella, and J. N. Brady. 1998. Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J. Virol. 72:6348.
23. Butscher, W. G., C. M. Haggerty, S. Chaudhry, and K. Gardner. 2001. Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells. J. Biol. Chem. 276:27647.
24. Butscher, W. G., C. Powers, M. Olive, C. Vinson, and K. Gardner. 1998. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-I/CREB2. J. Biol. Chem. 273:552.
25. Pestell, R. G., C. Albanese, G. Watanabe, R. J. Lee, P. Lastowiecki, L. Zon, M. Ostrowski, and J. L. Jameson. 1996. Stimulation of the P-450 side chain cleavage enzyme (CYP11A) promoter through ras- and Ets-2-signaling pathways. Mol. Endocrinol. 10:1084.
26. Mittelstadt, P. R., and J. D. Ashwell. 1998. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression. Mol. Cell. Biol. 18:3744.
27. El Deiry, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler. and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817.
28. Juven, T., Y. Barak, A. Zauberman, D. L. George, and M. Oren. 1993. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8:3411.
29. Kern, S. E., J. A. Pietenpol, S. Thiagalingam, A. Seymour, K. W. Kinzler, and B. Vogelstein. 1992. Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256:827.
30. Lin, J., J. Chen, B. Elenbaas, and A. J. Levine. 1994. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 EIB 55-kD protein. Genes Dev. 8:1235.
31. El Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45.
32. Yuan, W., G. Condorelli, M. Caruso, A. Felsani, and A. Giordano. 1996. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem. 271:9009.
33. Powers, C., H. Krutzsch, and K. Gardner. 1996. Modulation of JunD/AP1 DNA binding activity by AF-1. J. Biol. Chem. 271:30089.
34. Schneider, U., H. U. Schwenk, and G. Bornkamm. 1977. Characterization of EBV-genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int. J. Cancer 19:621.
35. Gillis, S., and J. Watson. 1980. Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line. J. Exp. Med. 152:1709.
36. Cheng, J., and M. Haas. 1990. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines. Mol. Cell. Biol. 10:5502.
37. Ashcroft, M., and K. H. Vousden. 1999. Regulation of p53 stability. Oncogene 18:7637.
38. Vo, N., and R. H. Goodman. 2001. CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276:13505.
39. Grossman, S. R. 2001. p300/CBP/p53 interaction and regulation of the p53 response. Eur. J. Biochem. 268:2773.
40. Scoggin, K. E., A. Ulloa, and J. K. Nyborg. 2001. The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to mediate transcriptional activation. Mol. Cell. Biol. 21:5520.
41. Van Orden, K., J. P. Yan, A. Ulloa, and J. K. Nyborg. 1999. Binding of the human T-cell leukemia virus Tax protein to the coactivator CBP interferes with CBP-mediated transcriptional control. Oncogene 18:3766.
42. Yan, J. P., J. E. Garrus, H. A. Giebler, L. A. Stargell, and J. K. Nyborg. 1998. Molecular interactions between the coactivator CBP and the human T-cell leukemia virus Tax protein. J. Mol. Biol. 281:395.
43. Radhakrishnan, I., G. C. Perez-Alvarado, D. Parker, H. J. Dyson, M. R. Montminy, and P. E. Wright. 1997. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator: coactivator interactions. Cell 91:741.
44. Kobet, E., X. Zeng, Y, Zhu, D. Keller, and H. Lu. 2000. MDM2 inhibits p300-mediated p53 acetylation and activation by forming a ternary complex with the two proteins. Proc. Natl. Acad. Sci. USA 97:12547.
45. Rivera-Walsh, I., M. Waterfield, G. Xiao, A. Fong, and S. C. Sun. 2001. NF-κB signaling pathway governs TRAIL gene expression and human T-cell leukemia virus-I Tax-induced T-cell death. J. Biol. Chem. 276:40385.
46. Zehender, G., S. Varchetta, C. De Maddalena, C. Colasante, A. Riva, L. Meroni, M. Moroni, and M. Galli. 2001. Resistance to Fas-mediated apoptosis of human T-cell lines expressing human T-lymphotropic virus type-2 (HTLV-2) Tax protein. Virology 281:43.
47. Rivera, I., E. W. Harhaj, and S. C. Sun. 1998. Involvement of NF-AT in type I human T-cell leukemia virus Tax-mediated Fas ligand promoter transactivation. J. Biol. Chem. 273:22382.
48. Cui, H., D. H. Sherr, M. el Khatib, K. Matsui, D. J. Panka, A. Marshak-Rothstein, and S. T. Ju. 1996. Regulation of T-cell death genes: selective inhibition of FasL-but not Fas-mediated function. Cell. Immunol. 167:276.
49. Ginsberg, D., F. Mechta, M. Yaniv, and M. Oren. 1991. Wild-type p53 can down-modulate the activity of various promoters. Proc. Natl. Acad. Sci. USA 88:9979.
50. Lechner, M. S., D. H. Mack, A. B. Finicle, T. Crook, K. H. Vousden, and L. A. Laimins. 1992. Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J. 11:3045.
51. Chin, K. V., K. Ueda, L. Pastan, and M. M. Gottesman. 1992. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science 255:459.
52. Kwok, R. P., M. E. Laurance, J. R. Lundblad, P. S. Goldman, H. Shih, L. M. Connor, S. J. Marriott, and R. H. Goodman. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the coactivator CBP. Nature 380:642.
53. Lemasson, I., and J. K. Nyborg. 2001. Human T-cell leukemia virus type I tax repression of p73β is mediated through competition for the C/H1 domain of CBP. J. Biol. Chem. 276:15720.
54. Thut, C. J., J. A. Goodrich, and R. Tjian. 1997. Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev. 11:1974.
55. Jones, S. N., A. R. Hancock, H. Vogel, L. A. Donehower, and A. Bradley. 1998. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc. Natl. Acad. Sci. USA 95:15608.
56. Mora, P. T., K. Chandrasekaran, J. C. Hoffman, and V. W. McFarland. 1982. Quantitation of a 55K cellular protein: similar amount and instability in normal and malignant mouse cells. Mol. Cell. Biol. 2:763.
57. Oren, M., W. Maltzman, and A. J. Levine. 1981. Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol. Cell. Biol. 1:101.
58. Sarnow, P., Y. S. Ho, J. Williams, and A. J. Levine. 1982. Adenovirus Elb-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell 28:387.
59. Scheffner, M., B. A. Werness, J. M. Huibregtse, A. J. Levine, and P. M. Howley. 1990. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129.
60. Yeargin, J., J. Cheng, and M. Haas. 1992. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia. Leukemia 6(Suppl. 3):85S.
61. Van Parijs, L., A. Biuckians, A. Ibragimov, F. W. Alt, D. M. Willerford, and A. K. Abbas. 1997. Functional responses and apoptosis of CD25 (IL-2Ra)-deficient T cells expressing a transgenic antigen receptor. J. Immunol. 158:3738.
62. Kinoshita, T., M. Shimoyama, K. Tobinai, M. Ito, S. Ito, S. Ikeda, K. Tajima, K. Shimotohno, and T. Sugimura. 1989. Detection of mRNA for the tax1/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction. Proc. Natl. Acad. Sci. USA 86:5620.
63. Portis, T., W. J. Grossman, J. C. Harding, J. L. Hess, and L. Ratner. 2001. Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model. J. Virol. 75:2185.
64. Ratner, L., T. Portis, M. Robek, J. Harding, and W. Grossman. 2000. Studies of the immortalizing activity of HTLV type 1 Tax, using an infectious molecular clone and transgenic mice. AIDS Res. Hum. Retroviruses 16:1647.
65. Mercer, W. E., and R. Baserga. 1985. Expression of the p53 protein during the cell cycle of human peripheral blood lymphocytes. Exp. Cell Res. 160:31.
66. Cantemir, C., C. Cozmei, B. Scutaru, S. Nicoara, and E. Carasevici. 1997. p53 protein expression in peripheral lymphocytes from atrazine chronically intoxicated rats. Toxicol. Lett. 93:87.